AA
Azoy Alexander
Chief Accounting Officer
OFFICERM
Insider track record
CFONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Azoy Alexander, Chief Accounting Officer. Insider active across 1 company, notably Arcus Biosciences, Inc.. Aggregated, 18 reports have been published. Breakdown: 0 buy · 9 sells. Total volume traded: €265k. Activity tracked since 3 July 2023. The latest transaction was disclosed on 21 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Azoy Alexander
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
2,827 shares@ US$15.44Common StockSEC:0001771961-26-000006:0
2,827 shares@ US$30.00Common StockSEC:0001771961-26-000006:1
2,562 shares@ US$25.77040.0018% mcap20.5% of flowCommon StockSEC:0001771961-26-000004:0
21,050 shares0Common StockSEC:0001771961-26-000002:0
2,376 shares@ US$21.884314.0% of flowCommon StockSEC:0001771961-25-000014:0
1,900 shares@ US$13.330.0007% mcap50.0% of flowCommon StockSEC:0001771961-25-000009:0
2,831 shares@ US$13.0011.3% of flowCommon StockSEC:0001771961-25-000006:0
1,579 shares@ US$11.87975.9% of flowCommon StockSEC:0001771961-25-000003:0
17,100 shares0Common StockSEC:0001724521-25-000016:0
3,007 shares@ US$15.1715.9% of flowCommon StockSEC:0001724521-24-000187:0
2,969 shares@ US$16.0816.4% of flowCommon StockSEC:0001724521-24-000179:0
201 shares@ US$15.321.1% of flowCommon StockSEC:0001724521-24-000162:0
1,357 shares@ US$14.976.7% of flowCommon StockSEC:0001724521-24-000141:0
8,850 shares0Common StockSEC:0001724521-24-000028:0
68 shares@ US$18.210.4% of flowCommon StockSEC:0001724521-23-000073:0
647 shares@ US$17.743.8% of flowCommon StockSEC:0001724521-23-000068:0
282 shares@ US$14.951.4% of flowCommon StockSEC:0001724521-23-000024:0
1,018 shares@ US$20.416.9% of flowCommon StockSEC:0001209191-23-040964:0
About Azoy Alexander
Azoy Alexander is Chief Accounting Officer at Arcus Biosciences, Inc. The declarant has 16 filings in total, and across the 16 sampled filings from 2023-07-05 to 2026-06-01, the activity is mainly sales, with total sell volume of EUR 248582 and no buys reported.